Shaken, not stirred: mechanical stress testing of an IgG1 antibody.
暂无分享,去创建一个
Hanns-Christian Mahler | Wolfgang Friess | W. Friess | Hanns‐Christian Mahler | S. Kiese | Astrid Papppenberger | Sylvia Kiese | Astrid Papppenberger | Hanns-Christian Mahler
[1] Chung C. Hsu,et al. Effect of high shear on proteins , 2000, Biotechnology and bioengineering.
[2] John P. Gabrielson,et al. Quantitation of aggregate levels in a recombinant humanized monoclonal antibody formulation by size-exclusion chromatography, asymmetrical flow field flow fractionation, and sedimentation velocity. , 2007, Journal of pharmaceutical sciences.
[3] Hanns-Christian Mahler,et al. Protein aggregation: pathways, induction factors and analysis. , 2009, Journal of pharmaceutical sciences.
[4] John F. Carpenter,et al. Physical Stability of Proteins in Aqueous Solution: Mechanism and Driving Forces in Nonnative Protein Aggregation , 2003, Pharmaceutical Research.
[5] Chung C. Hsu,et al. Protein denaturation by combined effect of shear and air-liquid interface. , 1997, Biotechnology and bioengineering.
[6] L. Bell,et al. Effect of surfactants on the physical stability of recombinant human growth hormone. , 1995, Journal of pharmaceutical sciences.
[7] Robert Gurny,et al. High throughput screening of protein formulation stability: practical considerations. , 2007, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[8] Mike Hoare,et al. Studies of the effect of shear on globular proteins: Extension to high shear fields and to pumps , 1981 .
[9] A. Pavlou,et al. The therapeutic antibodies market to 2008. , 2005, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[10] C. Trägårdh,et al. Whey protein adsorption onto steel surfaces - effect of temperature, flow rate, residence time and aggregation , 2006 .
[11] R. Gurny,et al. Characterization of protein aggregation: the case of a therapeutic immunoglobulin. , 2007, Biochimica et biophysica acta.
[12] Y. J. Wang,et al. Dual effects of Tween 80 on protein stability. , 2008, International journal of pharmaceutics.
[13] S. Magdassi,et al. Native and Hydrophobically Modified Human Immunoglobulin G at the Air/Water Interface. , 2001, Journal of colloid and interface science.
[14] M. Manning,et al. Aggregation of recombinant human interferon gamma: kinetics and structural transitions. , 1998, Journal of pharmaceutical sciences.
[15] Henry Eyring,et al. Conformation Changes of Proteins , 1954 .
[16] M. Kerker. Classics and classicists of colloid and interface science: 1. Michael Faraday☆ , 1986 .
[17] R. Murphy,et al. Misbehaving proteins : protein (mis)folding, aggregation, and stability , 2006 .
[18] S. Charm,et al. Shear effects on enzymes , 1981 .
[19] Colleen E. Price,et al. Contribution of variable domains to the stability of humanized IgG1 monoclonal antibodies. , 2008, Journal of pharmaceutical sciences.
[20] H. Schellekens,et al. The immunogenicity of biopharmaceuticals. Lessons learned and consequences for protein drug development. , 2003, Developments in biologicals.
[21] B M Eckhardt,et al. A turbidimetric method to determine visual appearance of protein solutions. , 1994, Journal of pharmaceutical science and technology : the official journal of PDA.
[22] S. Tzannis,et al. Adsorption of a Formulated Protein on a Drug Delivery Device Surface , 1997 .
[23] V. Uversky. A GLYmmer of insight into fibril formation. , 2005, Structure.
[24] P Dunnill,et al. Action of shear on enzymes: Studies with alcohol dehydrogenase , 1979, Biotechnology and bioengineering.
[25] P. Corry,et al. Employment of a turbidimetric assay system to measure heat-induced protein aggregation , 1992 .
[26] M. R. Zakin,et al. Cavitation thermometry using molecular and continuum sonoluminescence , 1996 .
[27] M. Manning,et al. Heterogeneous nucleation-controlled particulate formation of recombinant human platelet-activating factor acetylhydrolase in pharmaceutical formulation. , 2005, Journal of pharmaceutical sciences.
[28] M. Kerker. Classics and classicists of colloid and interface science: 6. John Tyndall , 1987 .
[29] Wen-Yih Chen,et al. The effects of denaturants on protein conformation and behavior at air/solution interface. , 2005, Colloids and surfaces. B, Biointerfaces.
[30] J L Cleland,et al. Tween protects recombinant human growth hormone against agitation-induced damage via hydrophobic interactions. , 1998, Journal of pharmaceutical sciences.
[31] J L Cleland,et al. The development of stable protein formulations: a close look at protein aggregation, deamidation, and oxidation. , 1993, Critical reviews in therapeutic drug carrier systems.
[32] W Wang,et al. Instability, stabilization, and formulation of liquid protein pharmaceuticals. , 1999, International journal of pharmaceutics.
[33] J. Philo. Is any measurement method optimal for all aggregate sizes and types? , 2006, The AAPS Journal.
[34] J. Weiss,et al. Structural and functional changes in ultrasonicated bovine serum albumin solutions. , 2007, Ultrasonics sonochemistry.
[35] T. L. Donaldson,et al. Kinetics of protein denaturation at gas—liquid interfaces , 1980 .
[36] J. Mitchell,et al. The surface coagulation of proteins during shaking. , 1970, Journal of colloid and interface science.
[37] Hanns-Christian Mahler,et al. Induction and analysis of aggregates in a liquid IgG1-antibody formulation. , 2005, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[38] Wei Wang,et al. Antibody structure, instability, and formulation. , 2007, Journal of pharmaceutical sciences.
[39] S. Guilbert,et al. Mechanism of heat and shear mediated aggregation of wheat gluten protein upon mixing. , 2002, Biomacromolecules.
[40] Huub Schellekens,et al. Factors influencing the immunogenicity of therapeutic proteins. , 2005, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[41] M C Manning,et al. Inhibition of stress-induced aggregation of protein therapeutics. , 1999, Methods in enzymology.
[42] A. Rosenberg,et al. Effects of protein aggregates: An immunologic perspective , 2006, The AAPS Journal.
[43] S. Charman,et al. Techniques for Assessing the Effects of Pharmaceutical Excipients on the Aggregation of Porcine Growth Hormone , 1993, Pharmaceutical Research.
[44] S. Swanson,et al. Detection of neutralizing anti-therapeutic protein antibodies in serum or plasma samples containing high levels of the therapeutic protein. , 2006, Journal of immunological methods.
[45] Hanns‐Christian Mahler,et al. Behaviour of polysorbate 20 during dialysis, concentration and filtration using membrane separation techniques. , 2008, Journal of pharmaceutical sciences.
[46] M. Manning,et al. Effect of Tween 20 on freeze-thawing- and agitation-induced aggregation of recombinant human factor XIII. , 1998, Journal of pharmaceutical sciences.
[47] C. Branden,et al. Introduction to protein structure , 1991 .
[48] S. Colombié,et al. Lysozyme inactivation under mechanical stirring: effect of physical and molecular interfaces. , 2001, Enzyme and microbial technology.
[49] B. Chang,et al. Surface-induced denaturation of proteins during freezing and its inhibition by surfactants. , 1996, Journal of pharmaceutical sciences.
[50] T. Randolph,et al. Stability of Protein Formulations: Investigation of Surfactant Effects by a Novel EPR Spectroscopic Technique , 2004, Pharmaceutical Research.